BKD:NYE-Brookdale Senior Living Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 6.75

Change

-0.02 (-0.30)%

Market Cap

USD 1.33B

Volume

1.63M

Analyst Target

USD 4.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Brookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). The Independent Living segment owns or leases communities comprising independent and assisted living units in a single community that are primarily designed for middle to upper income seniors. The Assisted Living and Memory Care segment owns or leases communities consisting of freestanding, multi-story communities and freestanding, single-story communities, which offer housing and 24-hour assistance with activities of daily living for the Company's residents. This segment also operates memory care communities for residents with Alzheimer's and other dementias. The CCRCs segment owns or leases communities that provides various living arrangements, such as independent and assisted living, memory care, and skilled nursing; and services to accommodate various levels of physical ability and healthcare needs. It also manages communities on behalf of others. Brookdale Senior Living Inc. was incorporated in 2005 and is headquartered in Brentwood, Tennessee. Address: 111 Westwood Place, Brentwood, TN, United States, 37027

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

+2.39 (+0.60%)

USD 101.08B
THC Tenet Healthcare Corporation

+4.11 (+2.62%)

USD 15.77B
UHS Universal Health Services Inc

+2.41 (+1.04%)

USD 15.68B
DVA DaVita HealthCare Partners Inc

-1.06 (-0.65%)

USD 13.72B
EHC Encompass Health Corp

+1.13 (+1.24%)

USD 9.38B
CHE Chemed Corp

-0.13 (-0.02%)

USD 8.66B
ARDT Ardent Health Partners, Inc.

-0.14 (-0.81%)

USD 2.59B
NHC National HealthCare Corporatio..

-0.76 (-0.61%)

USD 1.92B
AMN AMN Healthcare Services Inc

+0.71 (+1.54%)

USD 1.75B
AGL agilon health Inc

+0.35 (+9.62%)

USD 1.50B

ETFs Containing BKD

DXSD:F 10.59 % 0.00 %

N/A

N/A
DXSD:XETRA 10.59 % 0.00 %

N/A

N/A
ESIE:LSE iShares MSCI Europe Energ.. 10.39 % 0.00 %

-0.02 (0.00%)

USD 0.12B
ESIE:XETRA iShares MSCI Europe Energ.. 10.33 % 0.00 %

N/A

USD 0.15B
FMI:PA Amundi Index Solutions - .. 9.08 % 0.00 %

-0.17 (0.00%)

USD 0.07B
EYED:LSE iShares MSCI Europe Energ.. 9.01 % 0.00 %

-0.01 (0.00%)

N/A
STN:PA SPDR® MSCI Europe Energy.. 8.25 % 0.00 %

+0.08 (+0.00%)

USD 0.92B
SPYN:XETRA SPDR® MSCI Europe Energy.. 8.25 % 0.00 %

+0.04 (+0.00%)

USD 0.99B
STNX:SW SPDR® MSCI Europe Energy.. 8.25 % 0.00 %

-0.82 (0.00%)

USD 0.94B
ENGE:LSE SPDR® MSCI Europe Energy.. 7.90 % 0.00 %

N/A

N/A
EXH1:XETRA iShares STOXX Europe 600 .. 7.19 % 0.00 %

+0.03 (+0.00%)

USD 0.73B
SXEPEX:SW iShares STOXX Europe 600 .. 7.19 % 0.00 %

N/A

USD 0.08B
DBXI:XETRA Xtrackers FTSE MIB UCITS .. 6.66 % 0.00 %

-0.12 (0.00%)

USD 0.05B
SXRY:F iShares FTSE MIB UCITS 6.64 % 0.00 %

N/A

USD 0.23B
CSMIB:SW iShares VII PLC - iShares.. 6.56 % 0.00 %

N/A

N/A
MIB:PA Lyxor FTSE MIB (DR) UCITS.. 6.49 % 0.00 %

-0.13 (0.00%)

USD 0.42B
SXRY:XETRA iShares FTSE MIB UCITS 6.46 % 0.00 %

-0.52 (0.00%)

USD 0.21B
CMB1:LSE iShares FTSE MIB UCITS 6.26 % 0.00 %

-96.00 (0.00%)

USD 0.23B
DXSA:XETRA Xtrackers - Euro Stoxx Se.. 4.30 % 0.00 %

N/A

USD 0.26B
XD3E:LSE Xtrackers Euro Stoxx Qual.. 4.14 % 0.00 %

-6.50 (0.00%)

USD 0.25B
UC90:LSE UBS (Irl) Fund Solutions .. 3.07 % 0.00 %

+20.50 (+0.00%)

USD 0.01B
UIQI:F UBS (Irl) Fund Solutions .. 3.04 % 0.00 %

-1.64 (0.00%)

USD 0.31B
UIQI:XETRA UBSs plc - MSCI AC Asia E.. 3.04 % 0.00 %

-0.74 (0.00%)

USD 0.31B
UC48:LSE UBSs plc - MSCI AC Asia E.. 3.04 % 0.00 %

-100.00 (0.00%)

USD 0.31B
AJEUAS:SW UBS (Irl) Fund Solutions .. 3.04 % 0.00 %

N/A

N/A
ELFC:XETRA Deka EURO iSTOXX® ex Fin.. 2.56 % 0.00 %

-0.06 (0.00%)

USD 0.30B
WTEE:F WisdomTree Europe Equity .. 2.13 % 0.00 %

N/A

USD 0.03B
WTEE:XETRA WisdomTree Europe Equity .. 2.13 % 0.00 %

-0.02 (0.00%)

USD 0.03B
EEI:SW WisdomTree Europe Equity .. 2.11 % 0.00 %

N/A

N/A
EEIA:SW WisdomTree Europe Equity .. 2.11 % 0.00 %

N/A

N/A
EVAE:PA BNP Paribas Easy ESG Equi.. 2.01 % 0.00 %

-0.28 (0.00%)

USD 0.04B
VALD:PA BNP Paribas Easy ESG Equi.. 2.01 % 0.00 %

-0.26 (0.00%)

USD 2.92M
VALD:F BNP Paribas Easy ESG Equi.. 2.01 % 0.00 %

+0.34 (+0.00%)

USD 0.07B
VALU:F BNP Paribas Easy - Equity.. 2.01 % 0.00 %

+1.90 (+0.00%)

USD 0.04B
VALD:XETRA BNP Paribas Easy ESG Equi.. 2.01 % 0.00 %

-0.16 (0.00%)

USD 0.07B
VALU:XETRA BNP Paribas Easy ESG Equi.. 2.01 % 0.00 %

-0.22 (0.00%)

USD 0.07B
VALD:SW BNP Paribas Easy ESG Equi.. 2.01 % 0.00 %

N/A

USD 2.94M
EWI iShares MSCI Italy ETF 0.00 % 0.47 %

-0.13 (0.00%)

N/A
IDOG ALPS International Sector.. 0.00 % 0.50 %

+0.06 (+0.00%)

USD 0.30B
UIVM VictoryShares Internation.. 0.00 % 0.35 %

+0.01 (+0.00%)

USD 0.23B
MIBX:LSE Lyxor UCITS FTSE MIB 0.00 % 0.00 %

-20.75 (0.00%)

N/A
UC14:LSE UBS (Irl) Fund Solutions .. 0.00 % 0.00 %

+0.52 (+0.00%)

N/A
UC15:LSE UBS (Irl) Fund Solutions .. 0.00 % 0.00 %

+26.50 (+0.00%)

N/A
ELFC:F Deka EURO iSTOXX ex Fin D.. 0.00 % 0.00 %

+0.10 (+0.00%)

N/A
EXH1:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

N/A
SPYN:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

+1.70 (+0.00%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.98% 48% F 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.98% 50% F 71% C-
Trailing 12 Months  
Capital Gain 56.98% 68% D+ 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 56.98% 68% D+ 93% A
Trailing 5 Years  
Capital Gain -13.68% 39% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.68% 39% F 18% F
Average Annual (5 Year Horizon)  
Capital Gain 26.77% 82% B 88% B+
Dividend Return 26.77% 82% B 86% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 73.90% 27% F 11% F
Risk Adjusted Return 36.23% 59% D- 54% F
Market Capitalization 1.33B 50% F 61% D-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector